nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—Serum creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0103	0.0145	CcSEcCtD
Alitretinoin—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.0102	0.0142	CcSEcCtD
Alitretinoin—Skin infection—Lamivudine—hepatitis B	0.00999	0.014	CcSEcCtD
Alitretinoin—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.00932	0.013	CcSEcCtD
Alitretinoin—Autoimmune disorder—Lamivudine—hepatitis B	0.00904	0.0126	CcSEcCtD
Alitretinoin—RARG—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00865	0.0314	CbGpPWpGaD
Alitretinoin—RXRA—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00854	0.031	CbGpPWpGaD
Alitretinoin—Sensitisation—Lamivudine—hepatitis B	0.00844	0.0118	CcSEcCtD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00791	0.0287	CbGpPWpGaD
Alitretinoin—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00778	0.0109	CcSEcCtD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00776	0.0281	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors—HNF4A—hepatitis B	0.00759	0.0275	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00744	0.027	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00744	0.027	CbGpPWpGaD
Alitretinoin—RXRG—Nuclear Receptors—HNF4A—hepatitis B	0.00694	0.0252	CbGpPWpGaD
Alitretinoin—Hoarseness—Lamivudine—hepatitis B	0.00686	0.00959	CcSEcCtD
Alitretinoin—RARB—Nuclear Receptors—HNF4A—hepatitis B	0.0068	0.0247	CbGpPWpGaD
Alitretinoin—Bone pain—Adefovir Dipivoxil—hepatitis B	0.00664	0.00928	CcSEcCtD
Alitretinoin—RARA—Nuclear Receptors—HNF4A—hepatitis B	0.00652	0.0237	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptors—HNF4A—hepatitis B	0.00652	0.0237	CbGpPWpGaD
Alitretinoin—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.00636	0.00889	CcSEcCtD
Alitretinoin—Tenderness—Telbivudine—hepatitis B	0.00613	0.00858	CcSEcCtD
Alitretinoin—Chest discomfort—Telbivudine—hepatitis B	0.00605	0.00846	CcSEcCtD
Alitretinoin—Rhabdomyolysis—Telbivudine—hepatitis B	0.00605	0.00846	CcSEcCtD
Alitretinoin—Tretinoin—CYP2A6—hepatitis B	0.00602	0.634	CrCbGaD
Alitretinoin—RARG—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.006	0.0217	CbGpPWpGaD
Alitretinoin—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.00597	0.00835	CcSEcCtD
Alitretinoin—Cardiomyopathy—Lamivudine—hepatitis B	0.00589	0.00825	CcSEcCtD
Alitretinoin—Suicide—Lamivudine—hepatitis B	0.00581	0.00813	CcSEcCtD
Alitretinoin—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.00574	0.00803	CcSEcCtD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00548	0.0199	CbGpPWpGaD
Alitretinoin—Acidosis—Lamivudine—hepatitis B	0.00545	0.00762	CcSEcCtD
Alitretinoin—Musculoskeletal pain—Telbivudine—hepatitis B	0.00542	0.00758	CcSEcCtD
Alitretinoin—Neck pain—Telbivudine—hepatitis B	0.00542	0.00758	CcSEcCtD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00538	0.0195	CbGpPWpGaD
Alitretinoin—Suicide attempt—Lamivudine—hepatitis B	0.00531	0.00744	CcSEcCtD
Alitretinoin—Pregnancy—Lamivudine—hepatitis B	0.00531	0.00744	CcSEcCtD
Alitretinoin—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.00525	0.00735	CcSEcCtD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00516	0.0187	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00516	0.0187	CbGpPWpGaD
Alitretinoin—Completed suicide—Lamivudine—hepatitis B	0.00513	0.00718	CcSEcCtD
Alitretinoin—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00485	0.00678	CcSEcCtD
Alitretinoin—Folliculitis—Lamivudine—hepatitis B	0.0048	0.00671	CcSEcCtD
Alitretinoin—Respiratory tract infection—Lamivudine—hepatitis B	0.0048	0.00671	CcSEcCtD
Alitretinoin—Hypoxia—Lamivudine—hepatitis B	0.00475	0.00664	CcSEcCtD
Alitretinoin—Sepsis—Telbivudine—hepatitis B	0.00464	0.0065	CcSEcCtD
Alitretinoin—Blood triglycerides increased—Lamivudine—hepatitis B	0.0046	0.00644	CcSEcCtD
Alitretinoin—Blood creatinine increased—Entecavir—hepatitis B	0.00443	0.0062	CcSEcCtD
Alitretinoin—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00438	0.00613	CcSEcCtD
Alitretinoin—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00432	0.00605	CcSEcCtD
Alitretinoin—Renal impairment—Telbivudine—hepatitis B	0.00408	0.00571	CcSEcCtD
Alitretinoin—Pancreatitis—Entecavir—hepatitis B	0.00401	0.00561	CcSEcCtD
Alitretinoin—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00391	0.00547	CcSEcCtD
Alitretinoin—Pain in extremity—Telbivudine—hepatitis B	0.00388	0.00544	CcSEcCtD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00388	0.0141	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—MIF—hepatitis B	0.00387	0.014	CbGpPWpGaD
Alitretinoin—Hyperaesthesia—Lamivudine—hepatitis B	0.00384	0.00538	CcSEcCtD
Alitretinoin—Neutropenia—Entecavir—hepatitis B	0.00382	0.00535	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Entecavir—hepatitis B	0.0038	0.00531	CcSEcCtD
Alitretinoin—CYP1A2—Estrogen Receptor Pathway—NR0B2—hepatitis B	0.00369	0.0134	CbGpPWpGaD
Alitretinoin—RXRA—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00367	0.0133	CbGpPWpGaD
Alitretinoin—Dysphonia—Lamivudine—hepatitis B	0.00367	0.00513	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—MIF—hepatitis B	0.00364	0.0132	CbGpPWpGaD
Alitretinoin—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00361	0.00505	CcSEcCtD
Alitretinoin—Acne—Lamivudine—hepatitis B	0.00358	0.00501	CcSEcCtD
Alitretinoin—Renal failure—Entecavir—hepatitis B	0.00358	0.00501	CcSEcCtD
Alitretinoin—Renal failure—Adefovir Dipivoxil—hepatitis B	0.0035	0.00489	CcSEcCtD
Alitretinoin—Acitretin—ALB—hepatitis B	0.00348	0.366	CrCbGaD
Alitretinoin—Haematuria—Entecavir—hepatitis B	0.00347	0.00486	CcSEcCtD
Alitretinoin—Nasopharyngitis—Telbivudine—hepatitis B	0.00347	0.00486	CcSEcCtD
Alitretinoin—Gastritis—Telbivudine—hepatitis B	0.00344	0.00481	CcSEcCtD
Alitretinoin—Rhabdomyolysis—Lamivudine—hepatitis B	0.00341	0.00477	CcSEcCtD
Alitretinoin—RXRA—Nuclear Receptors—HNF4A—hepatitis B	0.0034	0.0123	CbGpPWpGaD
Alitretinoin—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00339	0.00474	CcSEcCtD
Alitretinoin—Abdominal distension—Telbivudine—hepatitis B	0.00338	0.00473	CcSEcCtD
Alitretinoin—Rectal haemorrhage—Lamivudine—hepatitis B	0.00334	0.00467	CcSEcCtD
Alitretinoin—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00334	0.00467	CcSEcCtD
Alitretinoin—Hepatitis—Entecavir—hepatitis B	0.00327	0.00458	CcSEcCtD
Alitretinoin—Drug interaction—Lamivudine—hepatitis B	0.00325	0.00455	CcSEcCtD
Alitretinoin—Oedema peripheral—Entecavir—hepatitis B	0.00322	0.00451	CcSEcCtD
Alitretinoin—Abdominal discomfort—Telbivudine—hepatitis B	0.00322	0.0045	CcSEcCtD
Alitretinoin—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00319	0.00447	CcSEcCtD
Alitretinoin—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00319	0.00446	CcSEcCtD
Alitretinoin—Hearing impaired—Lamivudine—hepatitis B	0.00317	0.00443	CcSEcCtD
Alitretinoin—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00317	0.00443	CcSEcCtD
Alitretinoin—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00315	0.00441	CcSEcCtD
Alitretinoin—Neutropenia—Telbivudine—hepatitis B	0.00314	0.00439	CcSEcCtD
Alitretinoin—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00313	0.00438	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00312	0.00437	CcSEcCtD
Alitretinoin—Inflammation—Lamivudine—hepatitis B	0.00311	0.00435	CcSEcCtD
Alitretinoin—Vasculitis—Lamivudine—hepatitis B	0.00309	0.00432	CcSEcCtD
Alitretinoin—Musculoskeletal pain—Lamivudine—hepatitis B	0.00305	0.00427	CcSEcCtD
Alitretinoin—Renal failure—Telbivudine—hepatitis B	0.00294	0.00412	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Telbivudine—hepatitis B	0.00293	0.00411	CcSEcCtD
Alitretinoin—CYP1A2—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00293	0.0106	CbGpPWpGaD
Alitretinoin—Wheezing—Lamivudine—hepatitis B	0.00293	0.0041	CcSEcCtD
Alitretinoin—Alopecia—Entecavir—hepatitis B	0.00289	0.00404	CcSEcCtD
Alitretinoin—Mental disorder—Entecavir—hepatitis B	0.00287	0.00401	CcSEcCtD
Alitretinoin—Malnutrition—Entecavir—hepatitis B	0.00285	0.00398	CcSEcCtD
Alitretinoin—Photophobia—Lamivudine—hepatitis B	0.00283	0.00396	CcSEcCtD
Alitretinoin—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00278	0.00389	CcSEcCtD
Alitretinoin—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00274	0.00383	CcSEcCtD
Alitretinoin—Mouth ulceration—Lamivudine—hepatitis B	0.00273	0.00382	CcSEcCtD
Alitretinoin—Back pain—Adefovir Dipivoxil—hepatitis B	0.00269	0.00376	CcSEcCtD
Alitretinoin—Hepatitis—Telbivudine—hepatitis B	0.00269	0.00376	CcSEcCtD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00269	0.00974	CbGpPWpGaD
Alitretinoin—Hypoaesthesia—Telbivudine—hepatitis B	0.00267	0.00374	CcSEcCtD
Alitretinoin—Pharyngitis—Telbivudine—hepatitis B	0.00267	0.00373	CcSEcCtD
Alitretinoin—RXRA—Recycling of bile acids and salts—ALB—hepatitis B	0.00265	0.00961	CbGpPWpGaD
Alitretinoin—Sepsis—Lamivudine—hepatitis B	0.00262	0.00366	CcSEcCtD
Alitretinoin—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00257	0.00359	CcSEcCtD
Alitretinoin—Lymphadenopathy—Lamivudine—hepatitis B	0.00257	0.00359	CcSEcCtD
Alitretinoin—Phlebitis—Lamivudine—hepatitis B	0.00254	0.00356	CcSEcCtD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.00254	0.0092	CbGpPWpGaD
Alitretinoin—Deafness—Lamivudine—hepatitis B	0.00245	0.00342	CcSEcCtD
Alitretinoin—Cough—Adefovir Dipivoxil—hepatitis B	0.00242	0.00339	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00241	0.00337	CcSEcCtD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00237	0.00859	CbGpPWpGaD
Alitretinoin—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00237	0.00331	CcSEcCtD
Alitretinoin—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00237	0.00331	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00235	0.00329	CcSEcCtD
Alitretinoin—Malnutrition—Telbivudine—hepatitis B	0.00234	0.00327	CcSEcCtD
Alitretinoin—Anaphylactic shock—Entecavir—hepatitis B	0.00232	0.00325	CcSEcCtD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.00232	0.00842	CbGpPWpGaD
Alitretinoin—Infection—Entecavir—hepatitis B	0.00231	0.00323	CcSEcCtD
Alitretinoin—Renal impairment—Lamivudine—hepatitis B	0.0023	0.00322	CcSEcCtD
Alitretinoin—Nervous system disorder—Entecavir—hepatitis B	0.00228	0.00319	CcSEcCtD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.00228	0.00825	CbGpPWpGaD
Alitretinoin—Back pain—Telbivudine—hepatitis B	0.00226	0.00317	CcSEcCtD
Alitretinoin—Skin disorder—Entecavir—hepatitis B	0.00226	0.00316	CcSEcCtD
Alitretinoin—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00222	0.00311	CcSEcCtD
Alitretinoin—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00222	0.00311	CcSEcCtD
Alitretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00222	0.00804	CbGpPWpGaD
Alitretinoin—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.0022	0.00308	CcSEcCtD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.00218	0.00791	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.00218	0.00791	CbGpPWpGaD
Alitretinoin—Ill-defined disorder—Telbivudine—hepatitis B	0.00217	0.00304	CcSEcCtD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00217	0.00786	CbGpPWpGaD
Alitretinoin—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00216	0.00302	CcSEcCtD
Alitretinoin—Affect lability—Lamivudine—hepatitis B	0.00215	0.00302	CcSEcCtD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00213	0.00771	CbGpPWpGaD
Alitretinoin—Malaise—Telbivudine—hepatitis B	0.00211	0.00295	CcSEcCtD
Alitretinoin—Insomnia—Entecavir—hepatitis B	0.0021	0.00294	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00209	0.00756	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00209	0.00756	CbGpPWpGaD
Alitretinoin—Mood swings—Lamivudine—hepatitis B	0.00207	0.0029	CcSEcCtD
Alitretinoin—Somnolence—Entecavir—hepatitis B	0.00207	0.00289	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00207	0.00289	CcSEcCtD
Alitretinoin—Dyspepsia—Entecavir—hepatitis B	0.00205	0.00286	CcSEcCtD
Alitretinoin—Cough—Telbivudine—hepatitis B	0.00204	0.00286	CcSEcCtD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00204	0.00739	CbGpPWpGaD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00204	0.00739	CbGpPWpGaD
Alitretinoin—CYP1A2—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00204	0.00739	CbGpPWpGaD
Alitretinoin—Dehydration—Lamivudine—hepatitis B	0.00204	0.00285	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Entecavir—hepatitis B	0.00201	0.00281	CcSEcCtD
Alitretinoin—Fatigue—Entecavir—hepatitis B	0.002	0.0028	CcSEcCtD
Alitretinoin—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.002	0.00279	CcSEcCtD
Alitretinoin—Arthralgia—Telbivudine—hepatitis B	0.00199	0.00279	CcSEcCtD
Alitretinoin—Chest pain—Telbivudine—hepatitis B	0.00199	0.00279	CcSEcCtD
Alitretinoin—Myalgia—Telbivudine—hepatitis B	0.00199	0.00279	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00198	0.00277	CcSEcCtD
Alitretinoin—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00197	0.00276	CcSEcCtD
Alitretinoin—Discomfort—Telbivudine—hepatitis B	0.00197	0.00275	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00196	0.00274	CcSEcCtD
Alitretinoin—Nasopharyngitis—Lamivudine—hepatitis B	0.00196	0.00274	CcSEcCtD
Alitretinoin—Abdominal distension—Lamivudine—hepatitis B	0.0019	0.00267	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Entecavir—hepatitis B	0.0019	0.00266	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—MIF—hepatitis B	0.0019	0.00688	CbGpPWpGaD
Alitretinoin—Dysphagia—Lamivudine—hepatitis B	0.00189	0.00265	CcSEcCtD
Alitretinoin—Nervous system disorder—Telbivudine—hepatitis B	0.00187	0.00262	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00187	0.00678	CbGpPWpGaD
Alitretinoin—Thrombocytopenia—Telbivudine—hepatitis B	0.00187	0.00262	CcSEcCtD
Alitretinoin—Pancreatitis—Lamivudine—hepatitis B	0.00186	0.0026	CcSEcCtD
Alitretinoin—Skin disorder—Telbivudine—hepatitis B	0.00185	0.00259	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00185	0.00259	CcSEcCtD
Alitretinoin—Sweating increased—Lamivudine—hepatitis B	0.00184	0.00258	CcSEcCtD
Alitretinoin—Abdominal pain—Entecavir—hepatitis B	0.00184	0.00257	CcSEcCtD
Alitretinoin—Body temperature increased—Entecavir—hepatitis B	0.00184	0.00257	CcSEcCtD
Alitretinoin—Abdominal discomfort—Lamivudine—hepatitis B	0.00181	0.00254	CcSEcCtD
Alitretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.0018	0.00652	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—GGT2—hepatitis B	0.0018	0.00652	CbGpPWpGaD
Alitretinoin—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00179	0.00251	CcSEcCtD
Alitretinoin—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00179	0.00251	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00179	0.0065	CbGpPWpGaD
Alitretinoin—Dysuria—Lamivudine—hepatitis B	0.00177	0.00248	CcSEcCtD
Alitretinoin—Neutropenia—Lamivudine—hepatitis B	0.00177	0.00248	CcSEcCtD
Alitretinoin—Pollakiuria—Lamivudine—hepatitis B	0.00175	0.00245	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00174	0.00243	CcSEcCtD
Alitretinoin—Insomnia—Telbivudine—hepatitis B	0.00173	0.00242	CcSEcCtD
Alitretinoin—Paraesthesia—Telbivudine—hepatitis B	0.00171	0.0024	CcSEcCtD
Alitretinoin—CYP1A2—Xenobiotics—CYP2A6—hepatitis B	0.0017	0.00618	CbGpPWpGaD
Alitretinoin—Depression—Lamivudine—hepatitis B	0.00168	0.00235	CcSEcCtD
Alitretinoin—Dyspepsia—Telbivudine—hepatitis B	0.00168	0.00235	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00167	0.00234	CcSEcCtD
Alitretinoin—Asthenia—Entecavir—hepatitis B	0.00167	0.00233	CcSEcCtD
Alitretinoin—Renal failure—Lamivudine—hepatitis B	0.00166	0.00232	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Lamivudine—hepatitis B	0.00165	0.00231	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00165	0.00231	CcSEcCtD
Alitretinoin—Fatigue—Telbivudine—hepatitis B	0.00165	0.0023	CcSEcCtD
Alitretinoin—Stomatitis—Lamivudine—hepatitis B	0.00164	0.0023	CcSEcCtD
Alitretinoin—CYP1A2—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00164	0.00594	CbGpPWpGaD
Alitretinoin—Pain—Telbivudine—hepatitis B	0.00163	0.00228	CcSEcCtD
Alitretinoin—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00163	0.00228	CcSEcCtD
Alitretinoin—Sweating—Lamivudine—hepatitis B	0.00162	0.00226	CcSEcCtD
Alitretinoin—Pruritus—Adefovir Dipivoxil—hepatitis B	0.0016	0.00224	CcSEcCtD
Alitretinoin—Epistaxis—Lamivudine—hepatitis B	0.00159	0.00223	CcSEcCtD
Alitretinoin—Diarrhoea—Entecavir—hepatitis B	0.00159	0.00222	CcSEcCtD
Alitretinoin—Sinusitis—Lamivudine—hepatitis B	0.00158	0.00221	CcSEcCtD
Alitretinoin—RXRA—Biological oxidations—GGT2—hepatitis B	0.00158	0.00572	CbGpPWpGaD
Alitretinoin—Agranulocytosis—Lamivudine—hepatitis B	0.00157	0.0022	CcSEcCtD
Alitretinoin—Feeling abnormal—Telbivudine—hepatitis B	0.00157	0.0022	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Telbivudine—hepatitis B	0.00156	0.00218	CcSEcCtD
Alitretinoin—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00155	0.00217	CcSEcCtD
Alitretinoin—Dizziness—Entecavir—hepatitis B	0.00154	0.00215	CcSEcCtD
Alitretinoin—Hepatitis—Lamivudine—hepatitis B	0.00151	0.00212	CcSEcCtD
Alitretinoin—Body temperature increased—Telbivudine—hepatitis B	0.00151	0.00211	CcSEcCtD
Alitretinoin—Abdominal pain—Telbivudine—hepatitis B	0.00151	0.00211	CcSEcCtD
Alitretinoin—Hypoaesthesia—Lamivudine—hepatitis B	0.00151	0.00211	CcSEcCtD
Alitretinoin—Pharyngitis—Lamivudine—hepatitis B	0.0015	0.0021	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—NR0B2—hepatitis B	0.00149	0.00542	CbGpPWpGaD
Alitretinoin—Vomiting—Entecavir—hepatitis B	0.00148	0.00207	CcSEcCtD
Alitretinoin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00147	0.00531	CbGpPWpGaD
Alitretinoin—Rash—Entecavir—hepatitis B	0.00147	0.00205	CcSEcCtD
Alitretinoin—Dermatitis—Entecavir—hepatitis B	0.00146	0.00205	CcSEcCtD
Alitretinoin—Headache—Entecavir—hepatitis B	0.00146	0.00204	CcSEcCtD
Alitretinoin—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00144	0.00202	CcSEcCtD
Alitretinoin—Erythema multiforme—Lamivudine—hepatitis B	0.00143	0.002	CcSEcCtD
Alitretinoin—Rash—Adefovir Dipivoxil—hepatitis B	0.00143	0.002	CcSEcCtD
Alitretinoin—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00143	0.002	CcSEcCtD
Alitretinoin—Headache—Adefovir Dipivoxil—hepatitis B	0.00142	0.00199	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—FAS—hepatitis B	0.00141	0.00511	CbGpPWpGaD
Alitretinoin—CYP1A2—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00139	0.00503	CbGpPWpGaD
Alitretinoin—RXRA—Bile acid and bile salt metabolism—ALB—hepatitis B	0.00139	0.00503	CbGpPWpGaD
Alitretinoin—Nausea—Entecavir—hepatitis B	0.00138	0.00193	CcSEcCtD
Alitretinoin—Asthenia—Telbivudine—hepatitis B	0.00137	0.00192	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—NR0B2—hepatitis B	0.00137	0.00495	CbGpPWpGaD
Alitretinoin—Chills—Lamivudine—hepatitis B	0.00136	0.0019	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.00135	0.00491	CbGpPWpGaD
Alitretinoin—Pruritus—Telbivudine—hepatitis B	0.00135	0.00189	CcSEcCtD
Alitretinoin—Nausea—Adefovir Dipivoxil—hepatitis B	0.00135	0.00188	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—NR0B2—hepatitis B	0.00134	0.00486	CbGpPWpGaD
Alitretinoin—Alopecia—Lamivudine—hepatitis B	0.00134	0.00187	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—FAS—hepatitis B	0.00132	0.0048	CbGpPWpGaD
Alitretinoin—Malnutrition—Lamivudine—hepatitis B	0.00132	0.00184	CcSEcCtD
Alitretinoin—Erythema—Lamivudine—hepatitis B	0.00132	0.00184	CcSEcCtD
Alitretinoin—Diarrhoea—Telbivudine—hepatitis B	0.00131	0.00183	CcSEcCtD
Alitretinoin—Flatulence—Lamivudine—hepatitis B	0.0013	0.00182	CcSEcCtD
Alitretinoin—Tension—Lamivudine—hepatitis B	0.00129	0.00181	CcSEcCtD
Alitretinoin—RARA—Generic Transcription Pathway—NR0B2—hepatitis B	0.00128	0.00466	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—NR0B2—hepatitis B	0.00128	0.00466	CbGpPWpGaD
Alitretinoin—Nervousness—Lamivudine—hepatitis B	0.00128	0.00179	CcSEcCtD
Alitretinoin—Back pain—Lamivudine—hepatitis B	0.00128	0.00178	CcSEcCtD
Alitretinoin—Dizziness—Telbivudine—hepatitis B	0.00126	0.00177	CcSEcCtD
Alitretinoin—Tremor—Lamivudine—hepatitis B	0.00124	0.00173	CcSEcCtD
Alitretinoin—Ill-defined disorder—Lamivudine—hepatitis B	0.00122	0.00171	CcSEcCtD
Alitretinoin—Anaemia—Lamivudine—hepatitis B	0.00122	0.0017	CcSEcCtD
Alitretinoin—Vomiting—Telbivudine—hepatitis B	0.00121	0.0017	CcSEcCtD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—hepatitis B	0.00121	0.0044	CbGpPWpGaD
Alitretinoin—Rash—Telbivudine—hepatitis B	0.0012	0.00168	CcSEcCtD
Alitretinoin—Dermatitis—Telbivudine—hepatitis B	0.0012	0.00168	CcSEcCtD
Alitretinoin—Headache—Telbivudine—hepatitis B	0.0012	0.00167	CcSEcCtD
Alitretinoin—Malaise—Lamivudine—hepatitis B	0.00119	0.00166	CcSEcCtD
Alitretinoin—Syncope—Lamivudine—hepatitis B	0.00118	0.00165	CcSEcCtD
Alitretinoin—Loss of consciousness—Lamivudine—hepatitis B	0.00116	0.00162	CcSEcCtD
Alitretinoin—Cough—Lamivudine—hepatitis B	0.00115	0.00161	CcSEcCtD
Alitretinoin—Convulsion—Lamivudine—hepatitis B	0.00114	0.0016	CcSEcCtD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.00114	0.00412	CbGpPWpGaD
Alitretinoin—Nausea—Telbivudine—hepatitis B	0.00113	0.00159	CcSEcCtD
Alitretinoin—Arthralgia—Lamivudine—hepatitis B	0.00112	0.00157	CcSEcCtD
Alitretinoin—Chest pain—Lamivudine—hepatitis B	0.00112	0.00157	CcSEcCtD
Alitretinoin—Myalgia—Lamivudine—hepatitis B	0.00112	0.00157	CcSEcCtD
Alitretinoin—Anxiety—Lamivudine—hepatitis B	0.00112	0.00157	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00111	0.00156	CcSEcCtD
Alitretinoin—Discomfort—Lamivudine—hepatitis B	0.00111	0.00155	CcSEcCtD
Alitretinoin—Dry mouth—Lamivudine—hepatitis B	0.0011	0.00154	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—CYP2A6—hepatitis B	0.00109	0.00395	CbGpPWpGaD
Alitretinoin—Confusional state—Lamivudine—hepatitis B	0.00108	0.00152	CcSEcCtD
Alitretinoin—Anaphylactic shock—Lamivudine—hepatitis B	0.00108	0.00151	CcSEcCtD
Alitretinoin—Oedema—Lamivudine—hepatitis B	0.00108	0.00151	CcSEcCtD
Alitretinoin—Infection—Lamivudine—hepatitis B	0.00107	0.0015	CcSEcCtD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00106	0.00385	CbGpPWpGaD
Alitretinoin—Shock—Lamivudine—hepatitis B	0.00106	0.00148	CcSEcCtD
Alitretinoin—Nervous system disorder—Lamivudine—hepatitis B	0.00106	0.00148	CcSEcCtD
Alitretinoin—Thrombocytopenia—Lamivudine—hepatitis B	0.00105	0.00147	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00105	0.00382	CbGpPWpGaD
Alitretinoin—Skin disorder—Lamivudine—hepatitis B	0.00105	0.00146	CcSEcCtD
Alitretinoin—Hyperhidrosis—Lamivudine—hepatitis B	0.00104	0.00146	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—HNF4A—hepatitis B	0.00104	0.00375	CbGpPWpGaD
Alitretinoin—Anorexia—Lamivudine—hepatitis B	0.00103	0.00144	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.00102	0.00368	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00101	0.00366	CbGpPWpGaD
Alitretinoin—Hypotension—Lamivudine—hepatitis B	0.00101	0.00141	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00098	0.00137	CcSEcCtD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—hepatitis B	0.00098	0.00355	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000974	0.00353	CbGpPWpGaD
Alitretinoin—Insomnia—Lamivudine—hepatitis B	0.000973	0.00136	CcSEcCtD
Alitretinoin—Paraesthesia—Lamivudine—hepatitis B	0.000966	0.00135	CcSEcCtD
Alitretinoin—Dyspnoea—Lamivudine—hepatitis B	0.000959	0.00134	CcSEcCtD
Alitretinoin—Somnolence—Lamivudine—hepatitis B	0.000957	0.00134	CcSEcCtD
Alitretinoin—RXRA—Biological oxidations—CYP2A6—hepatitis B	0.000955	0.00346	CbGpPWpGaD
Alitretinoin—Dyspepsia—Lamivudine—hepatitis B	0.000947	0.00133	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—HNF4A—hepatitis B	0.000947	0.00343	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000946	0.00343	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000946	0.00343	CbGpPWpGaD
Alitretinoin—Decreased appetite—Lamivudine—hepatitis B	0.000935	0.00131	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000934	0.00339	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKR1B1—hepatitis B	0.000929	0.00337	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKR1B1—hepatitis B	0.000929	0.00337	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000929	0.0013	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—HNF4A—hepatitis B	0.000929	0.00337	CbGpPWpGaD
Alitretinoin—Fatigue—Lamivudine—hepatitis B	0.000928	0.0013	CcSEcCtD
Alitretinoin—Pain—Lamivudine—hepatitis B	0.00092	0.00129	CcSEcCtD
Alitretinoin—Constipation—Lamivudine—hepatitis B	0.00092	0.00129	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—GGT2—hepatitis B	0.000891	0.00323	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GGT2—hepatitis B	0.000891	0.00323	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—HNF4A—hepatitis B	0.00089	0.00323	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—HNF4A—hepatitis B	0.00089	0.00323	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Lamivudine—hepatitis B	0.000887	0.00124	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Lamivudine—hepatitis B	0.00088	0.00123	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000874	0.00317	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase II conjugation—GGT2—hepatitis B	0.00086	0.00312	CbGpPWpGaD
Alitretinoin—Urticaria—Lamivudine—hepatitis B	0.000855	0.0012	CcSEcCtD
Alitretinoin—Body temperature increased—Lamivudine—hepatitis B	0.000851	0.00119	CcSEcCtD
Alitretinoin—Abdominal pain—Lamivudine—hepatitis B	0.000851	0.00119	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—GGT1—hepatitis B	0.00085	0.00308	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Lamivudine—hepatitis B	0.000793	0.00111	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—CTNNB1—hepatitis B	0.000793	0.00287	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—CDKN1A—hepatitis B	0.000774	0.00281	CbGpPWpGaD
Alitretinoin—Asthenia—Lamivudine—hepatitis B	0.000772	0.00108	CcSEcCtD
Alitretinoin—Pruritus—Lamivudine—hepatitis B	0.000761	0.00107	CcSEcCtD
Alitretinoin—RXRA—Biological oxidations—GGT1—hepatitis B	0.000746	0.0027	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—CTNNB1—hepatitis B	0.000745	0.0027	CbGpPWpGaD
Alitretinoin—Diarrhoea—Lamivudine—hepatitis B	0.000736	0.00103	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—CDKN1A—hepatitis B	0.000728	0.00264	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NR0B2—hepatitis B	0.000719	0.00261	CbGpPWpGaD
Alitretinoin—Dizziness—Lamivudine—hepatitis B	0.000712	0.000996	CcSEcCtD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000708	0.00257	CbGpPWpGaD
Alitretinoin—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000698	0.00253	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—FAS—hepatitis B	0.00069	0.0025	CbGpPWpGaD
Alitretinoin—Vomiting—Lamivudine—hepatitis B	0.000684	0.000957	CcSEcCtD
Alitretinoin—Rash—Lamivudine—hepatitis B	0.000678	0.000949	CcSEcCtD
Alitretinoin—Dermatitis—Lamivudine—hepatitis B	0.000678	0.000948	CcSEcCtD
Alitretinoin—Headache—Lamivudine—hepatitis B	0.000674	0.000943	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—NR0B2—hepatitis B	0.00067	0.00243	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NR0B2—hepatitis B	0.000658	0.00239	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NR0B2—hepatitis B	0.000645	0.00234	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TGFB1—hepatitis B	0.000641	0.00232	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—GGT1—hepatitis B	0.000639	0.00232	CbGpPWpGaD
Alitretinoin—Nausea—Lamivudine—hepatitis B	0.000639	0.000894	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000631	0.00229	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000622	0.00225	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NR0B2—hepatitis B	0.000619	0.00224	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NR0B2—hepatitis B	0.000619	0.00224	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TGFB1—hepatitis B	0.000602	0.00218	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TNF—hepatitis B	0.000598	0.00217	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000574	0.00208	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—NFKB1—hepatitis B	0.000573	0.00208	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000571	0.00207	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—hepatitis B	0.000562	0.00204	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000558	0.00202	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000557	0.00202	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000554	0.00201	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000548	0.00199	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CYP2A6—hepatitis B	0.00054	0.00196	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CYP2A6—hepatitis B	0.00054	0.00196	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000535	0.00194	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000534	0.00194	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000531	0.00193	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000526	0.00191	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—AKR1B1—hepatitis B	0.000517	0.00188	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000507	0.00184	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000503	0.00182	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000503	0.00182	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GGT2—hepatitis B	0.000503	0.00182	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—HNF4A—hepatitis B	0.000499	0.00181	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GOT2—hepatitis B	0.000488	0.00177	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GOT2—hepatitis B	0.000488	0.00177	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—IL6—hepatitis B	0.000483	0.00175	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—hepatitis B	0.000477	0.00173	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—HNF4A—hepatitis B	0.000464	0.00168	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000462	0.00167	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000458	0.00166	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000458	0.00166	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—HNF4A—hepatitis B	0.000456	0.00165	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IL6—hepatitis B	0.000454	0.00165	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—HNF4A—hepatitis B	0.000447	0.00162	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—hepatitis B	0.000446	0.00162	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000443	0.00161	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HNF4A—hepatitis B	0.000437	0.00158	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000431	0.00156	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—HNF4A—hepatitis B	0.000429	0.00155	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—HNF4A—hepatitis B	0.000429	0.00155	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.000426	0.00155	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GOT1—hepatitis B	0.000421	0.00153	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GGT1—hepatitis B	0.000421	0.00153	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GOT1—hepatitis B	0.000421	0.00153	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GGT1—hepatitis B	0.000421	0.00153	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000413	0.0015	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000411	0.00149	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase II conjugation—GGT1—hepatitis B	0.000407	0.00147	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000406	0.00147	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000404	0.00146	CbGpPWpGaD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000399	0.00145	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—CTNNB1—hepatitis B	0.000388	0.00141	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000384	0.00139	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000384	0.00139	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.00038	0.00138	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—CDKN1A—hepatitis B	0.000379	0.00138	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000373	0.00135	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000369	0.00134	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000364	0.00132	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000332	0.0012	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NR0B2—hepatitis B	0.000322	0.00117	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—TGFB1—hepatitis B	0.000314	0.00114	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.000305	0.0011	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000295	0.00107	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—TNF—hepatitis B	0.000293	0.00106	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000286	0.00104	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—TGFB1—hepatitis B	0.000286	0.00104	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000286	0.00104	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKR1B1—hepatitis B	0.000281	0.00102	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000279	0.00101	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000278	0.00101	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000278	0.00101	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000277	0.001	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000276	0.001	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GGT2—hepatitis B	0.00027	0.000978	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.00027	0.000977	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2—hepatitis B	0.00024	0.000868	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.000238	0.000863	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IL6—hepatitis B	0.000237	0.000858	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000231	0.000837	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.00023	0.000834	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—hepatitis B	0.000224	0.000812	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALB—hepatitis B	0.000224	0.000812	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HNF4A—hepatitis B	0.000223	0.00081	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000215	0.000781	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000215	0.000778	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000215	0.000778	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00021	0.000763	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000203	0.000735	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000201	0.00073	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.00019	0.000689	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TGFB1—hepatitis B	0.000187	0.000677	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—hepatitis B	0.000174	0.000633	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTEN—hepatitis B	0.000171	0.00062	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTEN—hepatitis B	0.000171	0.00062	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP2A6—hepatitis B	0.000163	0.000592	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000152	0.000552	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GOT2—hepatitis B	0.000148	0.000536	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—hepatitis B	0.000145	0.000525	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CTNNB1—hepatitis B	0.000134	0.000484	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NFKB1—hepatitis B	0.000129	0.00047	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GGT1—hepatitis B	0.000128	0.000462	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GOT1—hepatitis B	0.000128	0.000462	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000116	0.000421	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000114	0.000414	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKR1B1—hepatitis B	0.000112	0.000408	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000111	0.000404	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000111	0.000403	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000111	0.000401	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—hepatitis B	0.000108	0.000391	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GGT2—hepatitis B	0.000108	0.000391	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—hepatitis B	0.000101	0.000365	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	9.22e-05	0.000334	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	9.14e-05	0.000331	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKR1B1—hepatitis B	8.97e-05	0.000325	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	8.61e-05	0.000312	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GGT2—hepatitis B	8.6e-05	0.000312	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—hepatitis B	8.13e-05	0.000295	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	7.59e-05	0.000275	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—hepatitis B	6.78e-05	0.000246	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2A6—hepatitis B	6.53e-05	0.000237	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GOT2—hepatitis B	5.9e-05	0.000214	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	5.79e-05	0.00021	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2A6—hepatitis B	5.21e-05	0.000189	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTEN—hepatitis B	5.18e-05	0.000188	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GGT1—hepatitis B	5.1e-05	0.000185	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GOT1—hepatitis B	5.1e-05	0.000185	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.86e-05	0.000176	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GOT2—hepatitis B	4.71e-05	0.000171	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GGT1—hepatitis B	4.07e-05	0.000148	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GOT1—hepatitis B	4.07e-05	0.000148	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.71e-05	0.000134	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—hepatitis B	2.71e-05	9.83e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—hepatitis B	2.16e-05	7.85e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTEN—hepatitis B	2.07e-05	7.5e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTEN—hepatitis B	1.65e-05	5.99e-05	CbGpPWpGaD
